{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Onconetix, Inc.
Is Onconetix, Inc. technically bullish or bearish?
As of September 12, 2025, Onconetix, Inc. has shifted to a mildly bearish trend, influenced by bearish daily moving averages and Bollinger Bands, despite a mildly bullish MACD, with a year-to-date return of -94.4% compared to the S&P 500's 12.22%.
Is Onconetix, Inc. overvalued or undervalued?
As of August 29, 2024, Onconetix, Inc. is considered a risky investment due to its negative P/E ratio, unfavorable EV to EBITDA ratio, lack of a PEG ratio, and significant underperformance with a YTD return of -94.4% compared to the S&P 500's 12.22% gain.
Is Onconetix, Inc. technically bullish or bearish?
As of May 1, 2025, the market trend is mildly bearish due to conflicting indicators, with daily moving averages and weekly RSI suggesting bearish momentum, while the MACD shows bullish signals, leading to a cautious outlook.
What does Onconetix, Inc. do?
Onconetix, Inc. is a Micro Cap company in the Pharmaceuticals & Biotechnology industry. Financial metrics such as net sales and profit are not available, and it has a dividend yield of 0.00%.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
